Plain-English translation of NCT07529197 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study watches how people with severe post-infection fatigue (ME/CFS) respond to a treatment called immunoadsorption, which uses a special machine to filter out harmful immune cells from the blood. Researchers are collecting this real-world information to understand whether this treatment works and to prepare for a larger, more rigorous study in the future.
Right now, there is limited evidence about whether this immune cell removal treatment actually helps people with post-infection fatigue feel better and return to normal activities. This study will gather that evidence so doctors can make better decisions about offering this treatment to patients.
You likely qualify if…
You likely don't qualify if…
You will receive the immunoadsorption treatment over five days (on days 1, 2, 4, 6, and 8) at a clinic, following the standard medical schedule—this happens whether or not you join the study. Throughout the 12 months following treatment, you will complete monthly questionnaires at home about your fatigue, physical abilities, and quality of life. Before treatment and again at 2 and 6 months afterward, you will also visit the clinic for blood tests and simple physical tests (such as grip strength testing) to measure your recovery.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Germany